Concepedia

A. Mazzu

AM

6

Publications

290

Citations

6

H-Index

1984

Active since

Affiliations

Bayer (United States)(Current)

A. Mazzu is an author at Bayer (United States) specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

MedicinePharmacologyPharmacotherapyDrug AnalysisDrug DiscoveryMolecular PharmacologyChemistryCardiologyThrombosisToxicology

Publications per year

1984–2000

6

Publications

6

Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin

A. Mazzu · Clinical Pharmacology & Therapeutics · 2000 · 134 citations

Determination of extractable methylene dianiline in thermoplastic polyurethanes by HPLC

A. Mazzu, Clark Smith · Journal of Biomedical Materials Research · 1984 · 66 citations

Solvent Extraction, Engineering, Organic Chemistry +17

Thrombolytic therapy with urokinase reduces increased circulating endothelial adhesion molecules in acute myocardial infarction

Francesco Squadrito, Antonino Saitta, Domenica Altavilla et al. · Inflammation Research · 1996 · 43 citations

Thrombosis, Cardiovascular Disease, Thrombolytic Therapy +11

109 Lack of pharmacokinetic interaction between cerivastatin, a new HMG-CoA reductase inhibitor, and digoxin

John Lettieri, G.J. Krol, A. Mazzu et al. · Atherosclerosis · 1997 · 18 citations

Redox Signaling, Molecular Pharmacology, Oxysterol +8

Biopharmaceutical Profile of Cerivastatin: A Novel HMG-CoA Reductase Inhibitor

Wolfgang Mück, K. Ochmann, A. Mazzu et al. · Journal of International Medical Research · 1999 · 16 citations

Rows per page

1–5 of 6